Abstract
Background
Hepatocyte transplantation is a promising treatment for several liver diseases and can also be used as a “bridge” to liver transplantation in cases of liver failure. Although the first animal experiments with this technique began in 1967, it was first applied in humans only in 1992. Unfortunately, unequivocal evidence of transplanted human hepatocyte function has been obtained in only one patient with Crigler–Najjar syndrome type I and, even then, the amount of bilirubin–UDP-glucuronosyltransferase enzyme activity derived from the transplanted cells was not sufficient to eliminate the patient’s eventual need for organ transplantation.
Methods
A literature review was carried out using MEDLINE and library searches.
Results
This review considers the following: (1) alternatives or bridges to orthotopic liver transplantation (OLT); (2) solutions to the shortage of organs—the shortage of organ donors has impeded the development of human hepatocyte transplantation, and immortalized hepatocytes in particular could provide an unlimited supply of transplantable cells in a nearly future; (3) future directions. We review these efforts along with hepatocyte transplantation over the last 13 years.
Similar content being viewed by others
References
Demetrious AA, Levenson SM, Novikoff PM, Novikovv AB, Chowdhury NR, Whiting J, et al. Survival, organization, and function of microcarrier-attached hepatocytes transplanted in rats. Proc Natl Acad Sci USA. 1986;83:7475–9.
Sutherland DER, Numate M, Matas AJ, Simmons RL, Najaran JS. Hepatocellular transplantation in acute liver failure. Surgery. 1977;82:124–32.
Makowka L, Rotstein LE, Falk RE, Falk JA, Langer B, Nossal NA, et al. Reversal of toxic and anoxic induced hepatic failure by syngeneic, allogeneic, and xenogeneic hepatocyte transplantation. Surgery. 1980;88:244–53.
Arkadopoulos N, Chen SC, Khalili TM, Detry O, Jewitt WR, Lila H, et al. Transplantation of hepatocytes for prevention of intracranial hypertension in pigs with ischemic liver failure. Cell Transplant. 1998;7:357–63.
Ribeiro J, Nordlinger B, Ballet F, Cynober L, Coudray-Lucas C, Baudrimont M, et al. Intrasplenic hepatocellular transplantation corrects hepatic encephalopathy in portacaval-shunted rats. Hepatology. 1992;15:12–8.
Rugstad H, Robinson S, Yamoni C, Tashjian AJ. Transfer of bilirubin uridine-5-disphosphate-glucuronyltransferase to enzyme deficient rats. Science. 1970;170:553–5.
Wiederkehr J, Kondos G, Pollak R. Hepatocyte transplantation for the low-density lipoprotein receptor-deficient state. A study in the Watanabe rabbit. Transplantation. 1990;50:466–71.
Fox IJ, Roy Chowdhury J, Kaufman S, Goertzen T, Roy Chowdhury N, Warkentin P, et al. Treatment of Crigler–Najjar syndrome type I with hepatocyte transplantation. N Engl J Med. 1998;338:1422–6.
Tada K, Roy-Chowdhury N, Prasad V, Kim BH, Manchikalapudi P, Fox IJ, et al. Long-term amelioration of bilirubin glucuronidation defect in Gunn rats by transplanting genetically modified immortalized autologous hepatocytes. Cell Transplant. 1998;7:607–16.
Schumacher IK, Okamoto T, Kim BH, Chowdhury NR, Chowdhury JR, Fox IJ. Transplantation of conditionally immortalized hepatocytes to treat hepatic encephalopathy. Hepatology. 1996;24:337–43.
Cai J, Ito M, Westerman K, Kobayashi N, Leboulch P, Fox I. Construction of a non-tumorigenic rat hepatocyte cell line for transplantation: reversal of hepatocyte immortalization by site-specific excision of the SV40 T antigen. J Hepatol. 2000;33:701–8.
Westerman KA, Leboulch P. Reversible immortalization of mammalian cells mediated by retroviral transfer and site-specific recombination. Proc Natl Acad Sci USA. 1996;93:8971–6.
Nakamura J, Okamoto T, Schumacher IK, Tabei I, Chowdhury NR, Chowdhury JR, et al. Treatment of surgically induced acute liver failure by transplantation of conditionally immortalized hepatocytes. Transplantation. 1997;63:1541–7.
Ito M, Ito R, Yoshihara D, Ikeno M, Kamiya M, Suzuki N, et al. Immortalized hepatocytes using human artificial chromosome. Cell Transplant. 2008;17(1–2):165–71.
Afzelius BA, Schoental R. The ultrastructure of the enlarged hepatocytes induced in rats with a single oral dose of retrorsine, a pyrrolizidine (Senecio) alkaloid. J Ultrastruct Res. 1967;20(5):328–45.
Mito M, Kusano M, Kawaura Y. Hepatocyte transplantation in man. Transplant Proc. 1992;24(6):3052–3.
Mito M, Kusano M, Ohnishi T, Saito T, Evata H. Hepatocellular transplantation–morphological study on rat hepatocytes transplanted into rat spleen. Gastroenterol Jpn. 1978;13:480–90.
Ito M, Nagata H, Yamamoto T, Yoshihara D, Fox IJ, Miyakawa S. Intrasplenic hepatocyte transplantation prolonged the survival in Nagase analbuminemic rats with liver failure induced by common bile duct ligation. Cell Transplant. 2007;16(5):547–53.
Nagata H, Ito M, Shirota C, Edge A, McCowan TC, Fox IJ. Route of hepatocyte delivery affects hepatocyte engraftment in the spleen. Transplantation. 2003;76(4):732–4.
Kobayashi N, Ito M, Nakamura J, Cai J, Hammel JM, Fox IJ. Treatment of carbon tetrachloride and phenobarbital-induced chronic liver failure with intrasplenic hepatocyte transplantation. Cell Transplant. 2000;9(5):671–3.
Kobayashi N, Ito M, Nakamura J, Cai J, Cao C, Hammel JM, et al. The role of hepatocyte transplantation to treat chronic liver failure. Transplant Proc. 2000;32(7):2287–8.
Kobayashi N, Ito M, Nakamura J, Cai J, Hammel JM, Fox IJ. Hepatocyte transplantation improves liver function and prolongs survival in rats with decompensated liver cirrhosis. Transplant Proc. 1999;31(1–2):428–9.
Platt J. New directions for organ transplantation. Nature. 1998;392:11–7.
Ramirez P, Chavez R, Majado M, Munitiz V, Munoz A, Hernandez Q, et al. Life-supporting human complement regulatory decay accelerating factor transgenic pic liver xenograft maintains the metabolic function and coagulation in the nonhuman primate for up to 8 days. Transplantation. 2000;70:989–98.
Ito M, Nagata H, Cai J, Edge AS, Platt JL, Fox IJ. Treatment of cirrhosis and liver failure in rats by hepatocyte xenotransplantation. Gastroenterology. 2003;124(2):422–31.
Jo D, Nashabi A, Doxsee C, Lin Q, Unutmaz D, Chen J, et al. Epigenetic regulation of gene structure and function with a cell-permeable Cre recombinase. Nat Biotechnol. 2001;10:929–33.
Ito M, Cai J, Nagata H, Westerman KA, Lafleur D, Chowdhury JR, et al. Treatment of liver failure in rats with end-stage cirrhosis by transplantation of immortalized hepatocytes. Hepatology. 2002;36(2):386–94.
Zhang Y, Riesterer C, Ayrall A, Sablitzky F, Littlewood TD, Reth M. Inducible site-directed recombination in mouse embryonic stem cells. Nucleic Acids Res. 1996;24:543–8.
Berry M, Friend D. High yield preparation of isolated rat liver parenchymal cells: a biochemical and fine structural study. J Cell Biol. 1969;43:506–20.
Seglen P. Preparation of isolated rat liver cells. Methods Cell Biol. 1976;13:29–83.
Conjeevaram HS, Nagle A, Katz A, Kaminsky-Russ K, McCullough AJ, Mullen KD. Reversal of behavioral changes in rats subjected to portacaval shunt with oral Neomycin therapy. Hepatology. 1994;19:1245–50.
Blei AT, Olafsson S, Therrien G, Butterworth RJ. Ammonia-induced brain edema and intracranial hypertension in rats after portacaval shunt. Hepatology. 1994;19:1437–43.
Kobayashi N, Ito M, Nakamura J, Cai J, Gao C, Hammel J, et al. Hepatocyte transplantation in rats with decompensated cirrhosis. Hepatology. 2000;31:851–7.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Ito, M., Nagata, H., Miyakawa, S. et al. Review of hepatocyte transplantation. J Hepatobiliary Pancreat Surg 16, 97–100 (2009). https://doi.org/10.1007/s00534-008-0023-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00534-008-0023-0